CURRICULUM VITAE
Name: Dr Harjun Singh Brar A/L Mahinder Singh
Telephone number: 017-2436128
Email address: ami****001@yahoo.com
Nationality: Malaysian
CURRENT POSITION:
Medical Officer Jabatan Radioterapi Dan Onkologi Hospital Umum Sarawak
(August 2020 till today)
ACADEMIC ACHIEVEMENT & QUALIFICATIONS:
First Sechenov Moscow State Medical University: MD, 5 July 2013
Sarawak Advanced Life Support in Obstetric (SALSO) 15-16 June 2015
Good Clinical Practice Certification 19-21 August 2017
Basic Life Support Certification HKL 3 October 2017
Blue Ocean Strategy Online Training Certification 12 October 2017
FIFA World Cup 2018 Doping Control Officer Volunteer Certification 14 June 2018- 15 July 2018
WORK EXPERIENCE:
1. House Officer and Medical Officer: Sarawak General Hospital (December 2013-August 2016)
2. Medical Officer: Institute Radiotherapy and Oncology Hospital Kuala Lumpur (August 2016-August 2020)
MEMBERSHIP OF PROFESSIONAL ORGANIZATION
1. Malaysian Medical Association (Life Member)
2. Malaysian Oncological Society (Ordinary Member)
3. Persatuan Radioterapi Dan Onkologi Sarawak
(PROSAR) (Ordinary Member)
RESEARCH EXPERIENCE
1. Sub investigator- A randomized, double-blind, placebo-controlled, phase III study evaluating the efficacy and safety of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab as first line therapy for locally advanced or metastatic non-squamous and squamous non-small cell lung cancer subjects (CANOPY-1) (2019-2020)
2. Author- Outcome of children with diffuse intrinsic pontine glioma (DIPG) treated with radical radiotherapy at Hospital Kuala Lumpur between 2010-2017
讲座视频:0
论文摘要:3
19
0
0
日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2024-11-15 | 15:50-16:10 | 西安国际会展中心会议楼一层101会议室 |
Transformative Strategies in Oncology: Emerging Technologies Session 2 |
讲者 | A Case of Extraneural Metastases in Anaplastic Ependymoma |
2024-11-16 | 16:00-16:20 | 西安国际会展中心会议楼一层101会议室 |
Pioneering Cancer Research: Unveiling Breakthroughs in Oncology Session3 |
讲者 | Clinicopathological Profile and Biological Subtype of Breast Cancer Patients at a Tertiary Center in Nepal |